We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.61%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.8%
AUM
$10.9B
AUM Growth
+$1.02B
(+10%)
Cap. Flow
+$745M
Cap. Flow
% of AUM
6.83%
Top 10 Holdings %
Top 10 Hldgs %
30.62%
Holding
3,895
New
1,275
Increased
568
Reduced
596
Closed
1,134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$289M |
| 2 |
Linde
LIN
|
+$254M |
| 3 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$244M |
| 4 |
Moderna
MRNA
|
+$104M |
| 5 |
Honeywell
HON
|
+$96.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 2 |
ExxonMobil
XOM
|
+$206M |
| 3 |
Palantir
PLTR
|
+$130M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.8M |
| 5 |
Snowflake
SNOW
|
+$81.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.66% |
| 2 | Healthcare | 9.21% |
| 3 | Consumer Discretionary | 8.28% |
| 4 | Industrials | 6.28% |
| 5 | Materials | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.62B
| $6.76M | 0.06% |
+168,541
| New | +$6.86M |
|
252
Cardinal Health
CAH
$53.9B
| $6.67M | 0.06% |
116,782
+32,591
| +39% | +$1.9M |
|
253
Progressive
PGR
$123B
| $6.65M | 0.06% |
67,743
+61,607
| +1,004% | +$6.09M |
|
254
Gen Digital
GEN
$16.4B
| $6.61M | 0.06% |
242,883
+223,757
| +1,170% | +$5.57M |
|
255
AdvisorShares Pure US Cannabis ETF
MSOS
$858M
| $6.59M | 0.06% |
+164,852
| New | +$6.7M |
|
256
Humana
HUM
$43.7B
| $6.59M | 0.06% |
14,893
+3,824
| +35% | +$1.67M |
|
257
Texas Instruments
TXN
$252B
| $6.59M | 0.06% |
+34,263
| New | +$6.42M |
|
258
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.9B
| $6.52M | 0.06% |
75,625
-46,691
| -38% | -$3.84M |
|
259
State Street
STT
$50.6B
| $6.23M | 0.06% |
+75,707
| New | +$6.39M |
|
260
CME Group
CME
$96.3B
| $6.21M | 0.06% |
+29,192
| New | +$6.16M |
|
|
ABMD
261
DELISTED
Abiomed Inc
ABMD
| $6.13M | 0.06% |
+19,656
| New | +$6.03M |
|
262
Extra Space Storage
EXR
$31.3B
| $6.13M | 0.06% |
37,418
+34,341
| +1,116% | +$5.14M |
|
|
PFPT
263
DELISTED
Proofpoint, Inc.
PFPT
| $6.12M | 0.06% |
+35,217
| New | +$5.72M |
|
264
TransUnion
TRU
$15.1B
| $6.08M | 0.06% |
+55,352
| New | +$5.77M |
|
265
iShares Russell 2000 Growth ETF
IWO
$14.3B
| $6.05M | 0.06% |
19,411
-27,387
| -59% | -$8.24M |
|
266
Chemed
CHE
$7.07B
| $6.03M | 0.06% |
+12,701
| New | +$6.1M |
|
267
Jazz Pharmaceuticals
JAZZ
$15.9B
| $5.98M | 0.05% |
33,691
+27,093
| +411% | +$4.69M |
|
268
Coherent
COHR
$51.4B
| $5.95M | 0.05% |
+82,018
| New | +$5.77M |
|
269
PUT
AbbVie
ABBV
$443B
| $5.94M | 0.05% |
52,700
+46,200
| +711% | +$5.2M |
|
270
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.52B
| $5.92M | 0.05% |
37,245
-6,581
| -15% | -$979K |
|
271
Schneider National
SNDR
$6.26B
| $5.92M | 0.05% |
271,795
+232,166
| +586% | +$5.62M |
|
272
HEICO Corp
HEI
$49.8B
| $5.9M | 0.05% |
42,338
+22,292
| +111% | +$3.08M |
|
273
Palo Alto Networks
PANW
$270B
| $5.87M | 0.05% |
+94,998
| New | +$5.63M |
|
274
CubeSmart
CUBE
$9.39B
| $5.87M | 0.05% |
+126,682
| New | +$5.46M |
|
|
MGP
275
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $5.86M | 0.05% |
160,124
-118,761
| -43% | -$4.23M |
|
Similar funds
HRT Financial's Q2 2021 Portfolio in Review
As of Q2 2021, HRT Financial held 3,895 positions worth $10.9B, up 10% from $9.88B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
HRT Financial deployed $745M of net new capital in Q2 2021, opening 1,275 new positions and adding to 568 existing holdings. Its largest new stake was Linde: 872,603 shares worth $252M.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.1% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $330M trimmed.
- HRT Financial's largest Q2 2021 buy was Linde: 872,603 shares worth $252M.
- HRT Financial added most to Invesco QQQ Trust in Q2 2021, an estimated $289M increase.
- HRT Financial's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $330M.
- HRT Financial fully exited Palantir in Q2 2021, selling an estimated $130M.
- HRT Financial's ten largest holdings make up 31% of its $10.9B portfolio in Q2 2021.
- HRT Financial opened 1,275 new positions and closed 1,134 in Q2 2021.
- HRT Financial's portfolio value rose 10% quarter-over-quarter to $10.9B.
Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.